ABBV vs UPS: Which Is the Better Buy?

Side-by-side comparison of AbbVie Inc. and United Parcel Service, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-11.
AbbVie Inc. Β· Healthcare
$208.05
+4.5% upside to fair value
Grade C High Quality
VS
United Parcel Service, Inc. Β· Industrials
$101.69
+27.8% upside to fair value
Med Conviction Grade B-
QuantHub Verdict
UPS has more upside to fair value (+27.8%). ABBV trades at a lower forward P/E (14.9x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ABBV UPS
Current Price $208.05 $101.69
Fair Value Estimate $217.50 $130.00
Upside to Fair Value +4.5% +27.8%
Market Cap $367.9B $86.4B
Forward P/E 14.9x 15.1x
EV / EBITDA 16.7x 9.1x
Price / Sales 6.1x 0.9x
Price / FCF 20.9x 17.7x
Revenue Growth YoY +8.6% -2.5%
Gross Margin 83.7% 18.5%
Operating Margin 34.7% 9.56%
Return on Equity -129.24% 34.3%
Dividend Yield 3.2% 6.41%
FCF Yield 4.78% 5.66%
Analyst Consensus Buy Hold
Investment Thesis
ABBV β€” AbbVie Inc.
AbbVie is a leading diversified biopharmaceutical company navigating the post-Humira transition with strong momentum from Skyrizi and Rinvoq in immunology and continued growth in neuroscience. Full-year 2025 revenue reached $61.2 billion with a gross margin of 83.7% and operating margin of 34.7%, demonstrating operational strength despite the ongoing Humira erosion. Management guides to $67 billi…
UPS β€” United Parcel Service, Inc.
UPS is the world's largest integrated logistics network with 241,250 employees, operations in 200-plus countries, and 20.8 million packages per day, now in the decisive phase of its most consequential restructuring in 118 years. By deliberately cutting Amazon volume by more than 50 percent (Amazon was 10.6 percent of 2025 revenue), closing 22 to 24 facilities, and eliminating 30,000 positions, ma…
Accumulation Zones
Metric ABBV UPS
Zone Low $163.13 $95.00
Zone High $184.88 $112.00
In Buy Zone? No Yes
← ABBV Research    UPS Research β†’    All Research